Latest filing published 20 Nov 2020 for Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.), €13k.
No signal scores available.
This profile gathers the share dealings of Anthony Edward Dobranowski in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). Over a trading history stretching from 1 March 2016 to 20 November 2020, the count stands at 4 filings.
The open-market side counts 1 purchase for €1,642 alongside 2 sales for €17k. Taken together, the sales exceed the purchases by €15k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2020: 1 purchase and 2 sales on the market.
The record was last updated on 20 November 2020 with an open-market sale (€13k) in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). The clock since the last published purchase (5 March 2020) now reads 2,426 days. Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations